Petros Pharmaceuticals, Inc. (PTPI)
0.006
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Petros Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 0.1019M |
| September 30, 2024 | 0.5884M |
| June 30, 2024 | 0.3688M |
| March 31, 2024 | 1.556M |
| September 30, 2023 | 0.3891M |
| June 30, 2023 | 0.8666M |
| March 31, 2023 | 0.3191M |
| December 31, 2022 | 0.1778M |
| September 30, 2022 | 0.7359M |
| June 30, 2022 | 0.4212M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.4054M |
| September 30, 2021 | 0.2806M |
| June 30, 2021 | 0.50M |
| March 31, 2021 | 0.0192M |
| September 30, 2020 | 0.0368M |
| June 30, 2020 | 0.1316M |
| March 31, 2020 | 0.1394M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |
| Rockwell Medical, Inc. | 0.04M |